Rhumbline Advisers Azenta, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Azenta, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 156,373 shares of AZTA stock, worth $7.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

156,373

Previous 163,870 4.57%

Holding current value

$7.86 Million

Previous $8.62 Million 12.15%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$45.84 - $62.29 $343,662 - $466,988	-7,497 Reduced 4.57%	156,373 $7.57 Million
Q2 2024 Aug 01, 2024	SELL	$50.27 - $59.04 $318,309 - $373,841	-6,332 Reduced 3.72%	163,870 $8.62 Million
Q1 2024 May 09, 2024	SELL	$57.82 - $67.51 $1.2 Million - $1.41 Million	-20,814 Reduced 10.9%	170,202 $10.3 Million
Q4 2023 Feb 08, 2024	SELL	$44.02 - $66.3 $560,638 - $844,396	-12,736 Reduced 6.25%	191,016 $12.4 Million
Q3 2023 Nov 09, 2023	SELL	$44.08 - $57.76 $832,935 - $1.09 Million	-18,896 Reduced 8.49%	203,752 $10.2 Million
Q2 2023 Aug 08, 2023	SELL	$36.45 - $46.68 $276,801 - $354,487	-7,594 Reduced 3.3%	222,648 $10.4 Million
Q1 2023 May 11, 2023	SELL	$39.51 - $61.95 $492,729 - $772,578	-12,471 Reduced 5.14%	230,242 $10.3 Million
Q4 2022 Feb 14, 2023	BUY	$38.6 - $62.07 $724,599 - $1.17 Million	18,772 Added 8.38%	242,713 $14.1 Million
Q3 2022 Nov 10, 2022	BUY	$42.86 - $77.02 $401,769 - $721,985	9,374 Added 4.37%	223,941 $9.6 Million
Q2 2022 Aug 11, 2022	BUY	$64.69 - $85.07 $1.43 Million - $1.88 Million	22,104 Added 11.48%	214,567 $15.5 Million
Q1 2022 May 12, 2022	BUY	$76.3 - $103.81 $1,068 - $1,453	14 Added 0.01%	192,463 $16 Million
Q4 2021 Feb 10, 2022	BUY	$92.98 - $124.15 $361,971 - $483,315	3,893 Added 2.06%	192,449 $19.8 Million
Q3 2021 Nov 12, 2021	SELL	$77.49 - $109.17 $198,761 - $280,021	-2,565 Reduced 1.34%	188,556 $19.3 Million
Q2 2021 Aug 05, 2021	SELL	$86.59 - $107.47 $1.04 Million - $1.29 Million	-12,026 Reduced 5.92%	191,121 $18.2 Million
Q1 2021 May 06, 2021	SELL	$66.32 - $90.93 $352,225 - $482,929	-5,311 Reduced 2.55%	203,147 $16.6 Million
Q4 2020 Feb 10, 2021	BUY	$46.7 - $75.22 $212,718 - $342,627	4,555 Added 2.23%	208,458 $14.1 Million
Q3 2020 Nov 12, 2020	SELL	$42.77 - $56.69 $771,656 - $1.02 Million	-18,042 Reduced 8.13%	203,903 $9.43 Million
Q2 2020 Aug 13, 2020	SELL	$26.54 - $44.24 $453,754 - $756,371	-17,097 Reduced 7.15%	221,945 $9.82 Million
Q1 2020 May 06, 2020	SELL	$22.69 - $44.14 $63,554 - $123,636	-2,801 Reduced 1.16%	239,042 $7.29 Million
Q4 2019 Feb 05, 2020	BUY	$35.49 - $48.05 $457,182 - $618,980	12,882 Added 5.63%	241,843 $10.1 Million
Q3 2019 Oct 23, 2019	BUY	$30.18 - $41.75 $192,608 - $266,448	6,382 Added 2.87%	228,961 $8.48 Million
Q2 2019 Aug 14, 2019	BUY	$29.53 - $41.1 $280,180 - $389,956	9,488 Added 4.45%	222,579 $8.63 Million
Q1 2019 May 01, 2019	SELL	$24.38 - $33.75 $8,654 - $11,981	-355 Reduced 0.17%	213,091 $6.25 Million
Q4 2018 Jan 31, 2019	BUY	$23.22 - $35.29 $1.11 Million - $1.68 Million	47,590 Added 28.69%	213,446 $5.59 Million
Q3 2018 Nov 07, 2018	SELL	$28.71 - $39.6 $148,803 - $205,246	-5,183 Reduced 3.03%	165,856 $5.81 Million
Q2 2018 Aug 06, 2018	BUY	$24.88 - $36.36 $99,992 - $146,130	4,019 Added 2.41%	171,039 $5.58 Million
Q1 2018 May 02, 2018	BUY	$23.3 - $30.15 $84,555 - $109,414	3,629 Added 2.22%	167,020 $4.52 Million
Q4 2017 Feb 09, 2018	BUY	$22.54 - $34.39 $513,280 - $783,129	22,772 Added 16.19%	163,391 $3.9 Million
Q3 2017 Nov 06, 2017	BUY	$22.6 - $30.36 $3.18 Million - $4.27 Million	140,619	140,619 $4.27 Million

Others Institutions Holding AZTA

# of Institutions

335

Shares Held

49.2M

Call Options Held

186K

Put Options Held

405K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.77B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Azenta, Inc. Transaction History